Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Arch. pediatr. Urug ; 94(1): e204, 2023. ilus, tab
Article in Spanish | LILACS, UY-BNMED, BNUY | ID: biblio-1420116

ABSTRACT

Objetivo: describir las características de ocho pacientes pediátricos que se presentaron con síndrome inflamatorio multisistémico (MIS-C) asociado a SARS-CoV-2 y compromiso cardíaco. Material y métodos: estudio descriptivo, retrospectivo de ocho pacientes con edades entre 1 y 13 años, con diagnóstico de MIS-C y compromiso cardíaco, asistidos en el CHPR. Se analiza su historia clínica, evolución y tratamiento. Resultados: los pacientes presentaron fiebre en el 100%, exantema e hiperemia conjuntival en el 88%, síntomas digestivos en el 50%, insuficiencia respiratoria en el 25% y shock en el 50%. Todos requirieron ingreso a cuidados intensivos. La alteración de la contractilidad cardíaca estuvo presente en el 63% de los pacientes, fue leve y segmentaria en el 80%, el 60% requirió soporte inotrópico por 3 días, recuperando una función normal en 7 días. La insuficiencia mitral se presentó en el 25% y el derrame pericárdico en el 38%, ambos de grado leve. Un paciente presentó dilatación de arterias coronarias con Z score < 2. El 85% de los pacientes presentó alteraciones del ECG, en el 29% se trató de alteración en la repolarización, en el 29% intervalo QTc prolongado, en el 15% bloqueo atrioventricular de 1er grado y bloqueo incompleto de rama derecha. Un paciente tuvo fibrilación auricular por 3 días con remisión espontánea a ritmo sinusal. Las troponinas estuvieron altas en el 57% de los pacientes y el ProBNP elevado en el 100%. Todos recibieron inmunoglobulinas, metilprednisolona y aspirina. Conclusiones: se presentaron ocho pacientes pediátricos con MIS-C y compromiso cardíaco, el 50% se presentó en shock, todos requirieron ingreso a cuidados intensivos. El 85% presento alteraciones en el ECG. El 63% presentó compromiso de la contractilidad sectorial y leve, se normalizó en 7 días. El 60% requirió soporte inotrópico por una media de 3 días.


Objective: describe the characteristics of 8 children who presented Multisystem Inflammatory Syndrome associated with SARS-CoV2 infections (MIS-C) and cardiac involvement. Material and methods: descriptive, retrospective study of 8 patients of between 1 and 13 years of age, diagnosed with MIS-C and cardiac involvement, assisted at the Pereira Rossell Children Hospital, analysis of their medical records, evolution and treatment. Results: the patients showed: fever in 100% of the cases, rash and conjunctival hyperemia in 88%, digestive symptoms in 50%, respiratory failure in 25% and shock in 50%. All required admission to Intensive Care. Cardiac contractility alteration was present in 63% of patients, the affectation was mild and segmental in 80%, 60% required inotropic support for 3 days and recovered normal functions in 7 days. Mitral regurgitation was present in 25% of the cases and pericardial effusion in 38%, mild in both cases. One patient had dilated coronary arteries with a Z score <2. 85% of the patients presented ECG abnormalities, 29% present alteration of repolarization, 29% prolonged QTc, 15% 1st degree atrioventricular block and incomplete right bundle branch block. One patient had atrial fibrillation for 3 days with spontaneous remission to sinus rhythm. Troponins were increased in 57% of the patients and ProBNP elevated in 100%. All patients received Immunoglobulins, Methylprednisolone and Aspirin. Conclusions: we present eight pediatric patients with MIS-C and cardiac involvement, 50% suffered shock, all required admission to Intensive Care. ECG abnormalities were found in 85% of the patients. Mild and segmental contractility compromise was found in 63% of the patients and normalized in 7 days. 60% required inotropic support for a mean of 3 days.


Objetivo: descrever as características de 8 pacientes pediátricos que apresentaram Síndrome Inflamatória Multissistêmica (MIS-C) associada ao SARS-CoV-2 e comprometimento cardíaco. Material e métodos: estudo descritivo, retrospectivo, de oito pacientes com idade entre 1 e 13 anos, com diagnóstico de MIS-C e comprometimento cardíaco, assistidos pelo CHPR. Seu prontuário médico, evolução e tratamento são analisados. Resultados: os pacientes apresentaram febre em 100%, erupção cutânea e hiperemia conjuntival em 88%, sintomas digestivos em 50%, insuficiência respiratória em 25% e choque em 50%. Todos necessitaram de internação nos cuidados intensivos. A alteração da contratilidade cardíaca esteve presente em 63% dos pacientes, foi leve e segmentar em 80%, 60% necessitaram de suporte inotrópico por 3 dias, recuperando a função normal em 7 dias. A regurgitação mitral ocorreu em 25% dos pacientes e o derrame pericárdico em 38%, ambos de grau leve. Um paciente apresentou dilatação da artéria coronária com escore Z < 2. 85% dos pacientes apresentaram anormalidades no ECG, 29% foram alterações de repolarização, 29% intervalo QTc prolongado em bloqueio atrioventricular de 1º grau a 15% e bloqueio incompleto do ramo direito. Um paciente apresentou fibrilação atrial por 3 dias com remissão espontânea ao ritmo sinusal. As troponinas foram elevadas em 57% dos doentes e ProBNP elevado em 100%. Todos receberam imunoglobulinas, Metilprednisolona e aspirina. Conclusões: houve oito pacientes pediátricos com SMIM-C e comprometimento cardíaco, 50% em choque, todos necessitaram de internação em terapia intensiva. 85% apresentaram elevações no ECG. 63% apresentaram comprometimento setorial e de contratilidade leve, normalizados em 7 dias. 60% necessitaram de suporte inotrópico por uma média de 3 dias.


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Cardiovascular Diseases/diagnostic imaging , Systemic Inflammatory Response Syndrome/complications , COVID-19/complications , Methylprednisolone/therapeutic use , Heparin/therapeutic use , Cardiovascular Diseases/etiology , Cardiovascular Diseases/drug therapy , Intensive Care Units, Pediatric , Aspirin/therapeutic use , Treatment Outcome , Immunoglobulins, Intravenous/administration & dosage , Fibrinolytic Agents/therapeutic use , Heparin Antagonists/therapeutic use , Immunologic Factors/administration & dosage , Anti-Inflammatory Agents/therapeutic use
2.
Arch. pediatr. Urug ; 94(1): e207, 2023. tab
Article in Spanish | LILACS, UY-BNMED, BNUY | ID: biblio-1439319

ABSTRACT

Introducción: en marzo del 2021 se registró el pico de incidencia de COVID-19 en Uruguay y un aumento de la infección en pediatría. Objetivo: describir las características clínicas, el tratamiento y la evolución de una serie de menores de 15 años con SIM-Ped S hospitalizados en dos centros de salud. Metodología: estudio descriptivo, retrospectivo, de los niños hospitalizados entre el 1/3 y el 31/6 de 2021 que cumplieron los criterios diagnósticos de SIM-Ped de la OMS. Se analizan variables clínicas, paraclínicas, tratamiento y evolución. Resultados: se incluyeron 12 niños, mediana de edad 7 años (22 meses-10 años). Se presentaron complicación posinfecciosas en 8 y en el curso de la infección en 4. Las manifestaciones fueron: fiebre (media 6 días, rango 3-10), digestivas 10 y mucocutáneas 7. Se presentaron como enfermedad Kawasaki símil 5 y como shock 2. La infección por SARS CoV-2 se confirmó por PCR en 6, serología 4 y test antigénico 2. Recibieron tratamiento en cuidados moderados 8 e intensivos 4: inmunoglobulina 9, corticoides 11, heparina 7 y ácido acetilsalicílico 7. Presentaron dilatación de arterias coronarias 2, alteraciones valvulares 2, disminución de la FEVI 2 y derrame pericárdico 2. Todos evolucionaron favorablemente. Conclusiones: en estos centros, los primeros casos de SIMS-Ped S coincidieron con el pico de incidencia de COVID-19 en el país. Predominaron las formas postinfecciosas en escolares con manifestaciones digestivas. Este estudio puede contribuir al reconocimiento de esta entidad y adecuar los algoritmos nacionales de manejo.


Introduction: in March 2021, there was a peak incidence of COVID-19 and an increase in pediatric infections in Uruguay. Objective: describe the clinical characteristics, treatment and evolution of a group of children under 15 years of age with SIM-Ped S hospitalized in two health centers. Methodology: descriptive, retrospective study of children hospitalized between 3/1 and 6/31 of 2021 who met the WHO diagnostic criteria for SIM-Ped. Clinical and paraclinical variables, as well as treatment and evolution were analyzed. Results: 12 children were included, median age 7 years (22 months-10 years). Eight of them showed post-infectious complications and 4 of them had complications during the course of the infection. The manifestations were: fever (mean 6 days, range 3-10), digestive symptoms 10 and mucocutaneous 7. Five of them presented a Kawasaki-like disease and 2 of them shock. SARS CoV-2 infection was confirmed by PCR in 6 cases, serology in 4 and antigenic test in 2. Eight of them received treatment in moderate care and 4 of them in intensive care: immunoglobulin 9, corticosteroids 11, heparin 7 and acetylsalicylic acid 7. Two of them presented dilated arteries coronary , valvular alterations 2, decreased LVEF 2 and pericardial effusion 2. All progressed favorably. Conclusions: in these centers, the first cases of SIMS-Ped S coincided with the peak incidence of COVID-19 in the country. Post-infectious forms predominated in schoolchildren who showed digestive manifestations. This study may contribute to the recognition of this entity and to the adaptation of national management algorithms.


Introdução: em março de 2021, foi registrado no Uruguai um pico de incidência da COVID-19 e um aumento dos casos da infecção pediátrica. Objetivo: descrever as características clínicas, tratamento e evolução de uma série de crianças menores de 15 anos com SIM-Ped S internadas em dois centros de saúde. Metodologia: estudo descritivo, retrospectivo, de crianças internadas entre 1/3 e 31/6 de 2021 que preencheram os critérios diagnósticos da OMS para o SIM-Ped. Foram analisadas variáveis clínicas e para-clinicas, tratamento e evolução. Resultados: foram incluídas 12 crianças, com idade média de 7 anos (22 meses-10 anos). Oito delas apresentaram complicações pós-infecciosas e 4 delas durante o curso da infecção. As manifestações foram: febre (média de 6 dias, intervalo 3-10), digestivas 10 e mucocutânea 7. Cinco delas apresentaram doença de Kawasaki-like e 2 delas sofreram Shock. A infecção por SARS CoV-2 foi confirmada por PCR em 6, sorologia em 4 e teste antigênico em 2. Oito delas receberam tratamento em cuidados moderados e 4 delas em cuidados intensivos: imunoglobulina 9, corticosteroides 11, heparina 7 e ácido acetilsalicílico 7. Duas delas apresentaram artérias coronárias dilatadas 2, alterações valvares 2, diminuição da FEVE 2 e derrame pericárdico 2. Todas evoluíram favoravelmente. Conclusões: nesses centros, os primeiros casos de SIMS-Ped S coincidiram com um pico de incidência de COVID-19 no país. As formas pós-infecciosas predominaram em escolares com manifestações digestivas. Este estudo pode contribuir para o reconhecimento desta entidade e adaptar algoritmos nacionais de gestão.


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Systemic Inflammatory Response Syndrome/complications , COVID-19/complications , Heparin/therapeutic use , Cardiovascular Diseases/etiology , Cardiovascular Diseases/drug therapy , Receptors, Glucocorticoid/therapeutic use , Aspirin/therapeutic use , Retrospective Studies , Adrenal Cortex Hormones/therapeutic use , Systemic Inflammatory Response Syndrome/diagnosis , Systemic Inflammatory Response Syndrome/drug therapy , Digestive System Diseases/etiology , Digestive System Diseases/drug therapy , Antipyretics/therapeutic use , Fever/etiology , Fever/drug therapy , Symptom Assessment , Anti-Bacterial Agents/therapeutic use , Mucocutaneous Lymph Node Syndrome/etiology , Mucocutaneous Lymph Node Syndrome/drug therapy
3.
Arch. argent. pediatr ; 119(4): S198-S211, agosto 2021. tab, ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-1281043

ABSTRACT

La pandemia ocasionada por el nuevo coronavirus (SARS-CoV-2), declarada por la Organización Mundial de la Salud OMS) en marzo de 2020, afecta a un reducido número de pacientes pediátricos, quienes presentan, en su mayoría, compromiso respiratorio leve y evolución favorable. Sin embargo, en niños previamente sanos, comenzó a observarse un aumento de casos definidos como síndrome inflamatorio multisistémico (SIM-C) o similar a Kawasaki (Kawasaki-like) asociado a la enfermedad por el nuevo coronavirus (COVID-19) (KL-C) que evolucionan al shock y requieren internación en la unidad de cuidados intensivos.Los cuadros de SIM-C y los KL-C se caracterizan por fiebre, signos de inflamación, síntomas gastrointestinales y disfunción cardiovascular; las formas graves de presentación tienen mayor incidencia de hipotensión y/o shock. En el laboratorio se observan marcadores de inflamación, hipercoagulabilidad y daño miocárdico. El tratamiento farmacológico de primera línea consiste en la administración de inmunoglobulina por vía intravenosa más ácido acetilsalicílico por vía oral.Se recomienda un abordaje multidisciplinario para un diagnóstico certero y un tratamiento temprano y eficaz para disminuir la morbimortalidad.


The pandemic caused by the SARS-CoV-2 virus declared by the WHO in March 11th 2020, affects a small number of pediatric patients, who mostly present mild respiratory compromise and favorable evolution.However began to be observed in previously healthy children, an increase in cases defined as "Multisystemic Inflammatory Syndrome" (MIS-C) or "Kawasaki-like" post-COVID 19 (KL-C) that evolve to shock and require hospitalization in the Pediatric Intensive Care Unit.MIS-C and KL-C are characterized by fever; signs of inflammation, gastrointestinal symptoms, and cardiovascular dysfunction, associated with sever forms of presentation with higher incidence of hypotension and/or shock. In the laboratory, markers of inflammation, hypercoagulability and myocardial damage are observed. First-line drug treatment consists of intravenous immunoglobulin plus oral acetylsalicylic acid.A multidisciplinary approach is recommended for an accurate diagnosis and an early and effective treatment, in order to reduce morbidity and mortality.


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Adolescent , Systemic Inflammatory Response Syndrome/therapy , COVID-19/therapy , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Aspirin/therapeutic use , Immunoglobulins, Intravenous/therapeutic use , Systemic Inflammatory Response Syndrome/complications , Systemic Inflammatory Response Syndrome/diagnosis , Critical Care , Diagnosis, Differential , COVID-19/complications , COVID-19/diagnosis , Mucocutaneous Lymph Node Syndrome/complications , Mucocutaneous Lymph Node Syndrome/diagnosis , Mucocutaneous Lymph Node Syndrome/therapy
4.
Rev. chil. cardiol ; 39(3): 208-215, dic. 2020. tab, ilus, graf
Article in Spanish | LILACS | ID: biblio-1388056

ABSTRACT

INTRODUCCION: El Síndrome Inflamatorio Pediátrico Multisistémico (PIMS) ha emergido como una nueva enfermedad en niños, secundaria a infección por SARSCoV-2. Se caracteriza por presentar compromiso multiorgánico con parámetros inflamatorios elevados y manifestaciones clínicas graves, siendo el corazón el órgano más severamente comprometido. OBJETIVO: Describir las características clínicas y de laboratorio de 23 pacientes con diagnóstico de PIMS con compromiso cardiovascular hospitalizados en un centro único. MÉTODO: Se efectuó un estudio retrospectivo analizando los hallazgos clínicos y de laboratorio junto a las manifestaciones cardiovasculares que presentaron estos pacientes. RESULTADOS: 23/29 pacientes con PIMS (78%) presentaron manifestaciones digestivas y mucocutáneas. Las manifestaciones cardiovasculares fueron: Síndrome Kawasaki y "Kawasaki like" sin compromiso coronario en 15/23 (65%) y con compromiso coronario en 3 (13%). Shock en 9 pacientes (39%), injuria miocárdica- miocarditis en 8 (35%) y derrame pericárdico en 13 (56%). Trastornos del ritmo cardíaco se observaron en 6 pacientes (26%). La terapia más utilizada fue inmunoglobulina y corticoides. 18 /23 requirieron manejo en unidades de intermedio y/o intensivo. Un 70% de los pacientes se recuperó del compromiso cardiovascular antes del alta. CONCLUSIÓN: El compromiso cardiovascular en PIMS es la complicación más frecuente de esta enfermedad, que se acompaña de manifestaciones inmunológicas y hematológicas graves lo que hace necesario un tratamiento multidisciplinario para un mejor manejo de estos pacientes.


INTRODUCTION: Pediatric Multisystemic Inflammatory Syndrome (PIMS) has emerged as a new disease in children, secondary to SARSCoV-2 infection. It is characterized by multi-organ involvement with elevated inflammatory parameters and severe clinical manifestations, the heart being the organ most severely involved. OBJETIVE: to describe the clinical and laboratory characteristics of 23 patients diagnosed with PIMS with cardiovascular involvement hospitalized in a single center. METHOD: We conducted a retrospective study in which we analyzed the clinical and laboratory findings along with the cardiovascular manifestations presented by these patients. Results: 23/29 patients with PIMS and cardiovascular involvement were selected, 78% had digestive and mucocutaneous manifestations. Cardiovascular manifestations consisted of KawasakiKawasaki like syndrome without coronary involvement in 15/23 (65%) and coronary involvement in 3 (13%). Nine patients developed shock (39%), 8 (35%) myocardial injury in and 13 (56%) pericardial effusion.. Heart rhythm disorders were observed in 6 patients (26%). The main therapy was immunoglobulin and corticosteroids. 18 /23 required management in intermediate and/or intensive care unit. 70% of patients recovered from cardiovascular involvement before discharge. CONCLUSION: Cardiovascular involvement in PIMS is the most frequent complication of this disease, but it is associated with severe immunological and hematological manifestations, which makes necessary a multidisciplinary treatment for a better management


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Cardiovascular Diseases/etiology , Cardiovascular Diseases/epidemiology , Systemic Inflammatory Response Syndrome/complications , COVID-19/complications , Coronary Aneurysm/etiology , Coronary Aneurysm/epidemiology , Echocardiography , Chile , Retrospective Studies , Age Distribution , SARS-CoV-2 , Heart Injuries/etiology , Heart Injuries/epidemiology , Hospitalization , Mucocutaneous Lymph Node Syndrome/etiology , Mucocutaneous Lymph Node Syndrome/epidemiology
5.
Rev. cuba. med. mil ; 48(3): e296, jul.-set. 2019.
Article in Spanish | LILACS, CUMED | ID: biblio-1126638

ABSTRACT

Introducción: Existen enfermedades que tienen en su sustento, la respuesta inflamatoria,¿es posible identificar la diana que enmarca el efecto deletéreo de la respuesta inflamatoria? Objetivo: Analizar las expresiones de la respuesta inflamatoria sistémica y sus consecuencias en la morbilidad y mortalidad. Métodos: Se realizó una búsqueda, fundamentalmente en SciELO, con las palabras clave: respuesta inflamatoria sistémica, daño múltiple de órganos, respuesta inflamatoria y sus combinaciones; en idioma español. Se presenta una revisión narrativa a partir del análisis de los documentos obtenidos. Desarrollo: Los mecanismos defensivos de manera no controlada, producen autoagresión del endotelio vascular. La respuesta se acompaña de fallo inmunológico sistémico y disreactividad en la respuesta inflamatoria. La lesión del endotelio vascular, el incremento del consumo de oxígeno, citocinas elevadas en la circulación, activación de la cascada de coagulación y mediadores vasoactivos tienen influencia en esta respuesta. La isquemia intestinal, secundaria al síndrome compartimental abdominal, es causante directa de la translocación bacteriana. La inflamación persistente, asociada a un intenso proceso catabólico conduce a la caquexia y la inmunosupresión. Conclusión: Son múltiples las dianas que se activan en la respuesta inflamatoria sistémica, que explican su disbalance: la disfunción del endotelio vascular y la microcirculación, la disfunción mitocondrial y el estrés oxidativo, la citoprotección celular. Puede haber un punto de convergencia en la necesidad del diagnóstico temprano de esta respuesta disreactiva y en su intento de modulación oportuna(AU)


Introduction: There are diseases that have in their basics, the inflammatory response, is it possible to identify the target that frames the deleterious effect of the inflammatory response? Objective: To analyze the manifestations of the systemic inflammatory response and its consequences in morbidity and mortality. Methods: A search was performed, mainly in SciElo, with the key words: systemic inflammatory response, multiple organ damage, inflammatory response and their combinations; in Spanish language. A narrative review is presented based on the analysis of the documents obtained. Body: The defensive mechanisms in an uncontrolled way, produce self-aggression of the vascular endothelium. The response is accompanied by systemic immune failure and reactivity problems in the inflammatory response. Vascular endothelial injury, increased oxygen consumption, elevated cytokines in the circulation, activation of the coagulation cascade and vasoactive mediators have an influence on this response. Intestinal ischemia, secondary to abdominal compartment syndrome, is a direct cause of bacterial translocation. Persistent inflammation, associated with an intense catabolic process, leads to cachexia and immunosuppression. Conclusion: There are multiple targets that are activated in the systemic inflammatory response, which explain their imbalance: vascular endothelial dysfunction and microcirculation, mitochondrial dysfunction and oxidative stress, cell cytoprotection. There may be a point of convergence in the need for early diagnosis of this dis-reactive response and in its attempt at timely modulation(AU)


Subject(s)
Humans , Endothelium, Vascular , Systemic Inflammatory Response Syndrome/complications , Aggression , Inflammation , Ischemia , Microcirculation
6.
Article in English | WPRIM | ID: wpr-99847

ABSTRACT

Bacterial infection is an important cause of death in patients with liver cirrhosis. The aim of this study was to investigate the clinical characteristics and prognostic impact of bacterial infection in hospitalized patients with alcoholic liver disease (ALD). We retrospectively analyzed data from 409 patients consecutively admitted to a tertiary referral center with ALD diagnosis. Of a total of 544 admissions, 133 (24.4%) cases presented with bacterial infection, of which 116 were community-acquired whereas 17 were hospital-acquired. The common types of infection were pneumonia (38%), biliary tract infection (17%), soft tissue infection (12%), and spontaneous bacterial peritonitis (9%). Diabetes, serum Na or =20 mg/L, systemic inflammatory response syndrome (SIRS) positivity were independently associated with bacterial infection in patients with ALD. Overall 30-day and 90-day mortalities in patients with bacterial infection were significantly (P or =32 (HR, 2.3; 95% CI, 1.036-5.222, P = 0.041), and hemoglobin <12 g/dL (HR, 2.4; 95% CI, 1.081-5.450, P = 0.032) were independent predictors of short-term mortality. In conclusion, bacterial infection and SIRS positivity predicted short-term prognosis in hospitalized patients with ALD. A thorough evaluation at admission or on clinical deterioration is required to detect possible infection with prompt management.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Bacterial Infections/complications , C-Reactive Protein/analysis , Candida/isolation & purification , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Hemoglobins/analysis , Hospitalization , Linear Models , Liver Diseases, Alcoholic/complications , Patients , Prognosis , Proportional Hazards Models , Retrospective Studies , Risk Factors , Serum Albumin/analysis , Sodium/blood , Survival Analysis , Systemic Inflammatory Response Syndrome/complications , Tertiary Care Centers
7.
Rev. gastroenterol. Perú ; 34(3): 211-216, jul. 2014. ilus, tab
Article in Spanish | LILACS, LIPECS | ID: lil-728525

ABSTRACT

Objetivo: La inflamación sistémica empeora los trastornos circulatorios en el paciente cirrótico y recientemente el síndrome de respuesta inflamatoria sistémica (SRIS) podría ser un indicador pronóstico en ellos. El objetivo del estudio fue determinar si la presencia de SRIS al ingreso en pacientes cirróticos hospitalizados está asociada a complicaciones o mortalidad. Materiales y métodos: Estudio de cohortes retrospectiva, realizado en el Hospital Nacional Daniel Alcides Carrión. Se admitieron pacientes cirróticos hospitalizados desde julio 2008 hasta diciembre 2010 sin comorbilidades importantes, neoplasia maligna, infección VIH, o estancia fue menor a 72 horas. Se evaluó presencia de SRIS al ingreso y la aparición de complicaciones o muerte después de 72 horas del ingreso. Resultados: Fueron 150 pacientes cirróticos admitidos, se excluyeron 6, tres por supervivencia menor a las 72 horas, uno por neoplasia, uno por insuficiencia cardiaca severa y dos por insuficiencia renal crónica. En total 144 pacientes ingresaron al estudio, 95 (66%) pacientes presentaron SRIS al ingreso. No hubo diferencia significativa en cuanto a edad, sexo, etiología, en ambos grupos. SRIS estuvo asociado a mayores puntajes de MELD y Child-Pugh Turcotte. De los pacientes con SRIS, 41 (43%) se complicaron y 16 (16,8%) fallecieron, mientras que del grupo sin SRIS 5 (10,2%) se complicaron y 2 (4%) fallecieron, (p<0,0001y p=0,028 respectivamente). Las complicaciones más frecuentes fueron las infecciones y encefalopatía hepática. En el análisis multivariado SRIS estuvo asociado a complicaciones (p<0,006) mas no a mortalidad (p<0,276). Conclusiones: SRIS es frecuente en pacientes cirróticos hospitalizados y está asociado a complicaciones intrahospitalarias.


Objective: The systemic inflammation worsens circulatory disorders in cirrhotic patients and recently the systemic inflammatory response syndrome (SIRS) may be a prognostic indicator therein. The aim of the study was to determine whether the presence of SIRS at admission in hospitalized cirrhotic patients is associated with complications or mortality. Materials and methods: A retrospective cohorts study was conducted at the Daniel Alcides Carrion National Hospital. Hospitalized cirrhotic patients admitted from July 2008 to December 2010 without significant comorbidities, malignancy, HIV infection, or stay less than 72 hours were included. Presence of SIRS at admission and the occurrence of complications or death after 72 hours of admission were evaluated. Results: 150 cirrhotic patients were admitted, six were excluded; three for lower survival at 72 hours, one for neoplasia, one for severe heart failure and two for chronic renal failure. One hundred forty four patients were included, 95 (66%) patients had SIRS at admission. There was no significant difference in age, sex, etiology, in both groups. SIRS was associated with higher scores of MELD and Child-Turcotte Pugh. Of the group of patients with SIRS, 41 (43%) had complications and 16 (16.8%) died, while the group without SIRS 5 (10.2%) had complications and two (4%) died (p<0.0001 and p=0.028 respectively). The most common complications were infections and hepatic encephalopathy. In multivariate analysis SIRS was associated with complications (p<0.006) but not with mortality (p<0.276). Conclusions: SIRS is common in hospitalized cirrhotic patients and is associated with in-hospital complications.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Liver Cirrhosis/complications , Liver Cirrhosis/mortality , Systemic Inflammatory Response Syndrome/complications , Cohort Studies , Prognosis , Retrospective Studies
8.
Yonsei Medical Journal ; : 953-959, 2014.
Article in English | WPRIM | ID: wpr-113982

ABSTRACT

PURPOSE: Due to the seroepidemiological shift in hepatitis A (HA), its severity, mortality, and complications have increased in recent years. Thus, the aim of this study was to identify predictive factors associated with poor prognosis among patients with HA. MATERIALS AND METHODS: A total of 304 patients with HA admitted to our institution between July 2009 and June 2011 were enrolled consecutively. Patients with complications defined as acute liver failure (ALF) were evaluated, and mortality was defined as death or liver transplantation. RESULTS: The mean age of patients (204 males, 100 females) was 32 years. Eighteen (5.9%) patients had progressed to ALF. Of the patients with ALF, 10 patients (3.3%) showed spontaneous survival while 8 (2.6%) died or underwent liver transplantation. Multivariate regression analysis showed that Model for End-Stage Liver Disease (MELD) and systemic inflammatory response syndrome (SIRS) scores were significant predictive factors of ALF. Based on receiver operating characteristics (ROC) analysis, a MELD > or =23.5 was significantly more predictive than a SIRS score > or =3 (area under the ROC: 0.940 vs. 0.742, respectively). In addition, of patients with a MELD score > or =23.5, King's College Hospital criteria (KCC) and SIRS scores were predictive factors associated with death/transplantation in multivariate analysis. CONCLUSION: MELD and SIRS scores > or =23.5 and > or =3, respectively, appeared to be related to ALF development. In addition, KCC and SIRS scores > or =3 were valuable in predicting mortality of patients with a MELD > or =23.5.


Subject(s)
Adult , Female , Humans , Male , Hepatitis A/complications , Liver Failure, Acute/etiology , Multivariate Analysis , Prognosis , Prospective Studies , ROC Curve , Systemic Inflammatory Response Syndrome/complications
9.
Rev. bras. anestesiol ; 60(3): 247-258, maio-jun. 2010. ilus, tab, graf
Article in English, Portuguese | LILACS | ID: lil-549082

ABSTRACT

JUSTIFICATIVA E OBJETIVOS: O uso de manobras de hiperinsuflação pulmonar (MHP) reverte atelectasias intraoperatórias. Contudo, pode induzir resposta inflamatória sistêmica de origem pulmonar. O objetivo deste estudo foi testar o impacto da aplicação de MHP sobre a resposta inflamatória sistêmica e sobre a estrutura pulmonar em pacientes submetidos à anestesia subaracnoidea. MÉTODO: Após aprovação do Comitê de Ética institucional e obtenção do consentimento escrito pós-informado, 20 pacientes submetidos a procedimentos cirúrgicos de pequeno e médio porte foram alea torizados em dois grupos: 1) Controle (GC) e 2) MHP (GMHP). Uma hora após a instalação do bloqueio espinhal, foi realizada MHP no GMHP aplicando-se pressão positiva nas vias aéreas em dois níveis (BIPAP) com pressão expiratória de 20 cmH2O e pressão inspiratória de 20 cmH2O durante 1 a 2 minutos. TNFα, IL-1, IL-6, IL-8, IL-10 e IL-12 foram medidos no sangue através de técnica de citometria de fluxo nos momentos basal, 90, 180 e 780 minutos. Os volumes e peso pulmonares foram computados a partir de tomografias computadorizadas obtidas imediatamente após a cirurgia. RESULTADOS: A aplicação de MHP resultou em redução da fração de parênquima pulmonar não aerado (7,5 ± 4,3 por cento no Grupo Controle versus 4 ± 2,1 por cento no Grupo MHP, p = 0,02), sem alterações nos volumes pulmonares. Foi observada elevação progressiva nos valores plasmáticos das interleucinas IL-1, IL-6, IL-8 e IL-10, similar nos dois grupos. Os níveis plasmáticos de TNFα e IL-12 foram indetectáveis durante o estudo. CONCLUSÕES: A aplicação de MHP única reduziu a fração de atelectasias, porém não amplificou a resposta inflamatória observada em pacientes com pulmões normais submetidos a cirurgias de pequeno e médio portes sob anestesia subaracnoidea.


BACKGROUND AND OBJECTIVES: Lung hyperinflation maneuvers (LHM) reverse intraoperative atelectasis; however, they can lead to pulmonary-induced systemic inflammatory response. The objective of this study was to determine the impact of LHM on systemic inflammatory response and lung structure in patients undergoing subarachnoid block. METHODS: After approval by the Ethics Committee of the institution and signing the informed consent, 20 patients undergoing small and medium surgical procedures were randomly separated into two groups: 1) control (CG), and 2) LHM (LHMG). One hour after the spinal anesthesia, LHM was performed in LHMG by applying bilevel positive pressure in the airways (BIPAP) with an expiratory pressure of 20 cmH2O and inspiratory pressure of 20 cmH2O for 1 to 2 minutes. Blood levels of TNFα, IL-1, IL-6, IL-8, IL-10, and IL-12 were determined by flow cytometry at baseline and at 90, 180, and 780 minutes. Lung volumes and weights were determined using CT scans obtained immediately after the surgery. RESULTS: The use of LHM resulted in a reduction in the fraction of non-aerated pulmonary parenchyma (7.5 ± 4.3 percent, in the Control Group, vs. 4 ± 2.1 percent, in the LHM Group, p = 0.02) without changing pulmonary volumes. A progressive increase in plasma levels of IL-1, IL-6, IL-8, and IL-10, similar in both groups, was observed. Plasma levels of TNFα and IL-12 were undetectable during the study. CONCLUSIONS: The use of LHM reduced the incidence of atelectasis, but it did not amplify the inflammatory response in patients with normal lungs undergoing small and medium surgeries under subarachnoid block.


JUSTIFICATIVA Y OBJETIVOS: El uso de maniobras de hiperinsuflación pulmonar (MHP), revierte las atelectasias intraoperatorias, pero puede conllevar a una respuesta inflamatoria sistémica de origen pulmonar. Los objetivos de este estudio fueron comprobar el impacto de la aplicación de MHP sobre la respuesta inflamatoria sistémica y sobre la estructura pulmonar en pacientes sometidos a la anestesia subaracnoidea. MÉTODO: Después de la aprobación del Comité de Ética institucional y de la obtención del consentimiento informado, 20 pacientes sometidos a procedimientos quirúrgicos de pequeño y mediano porte, se separaron aleatoriamente en dos grupos: 1) control (GC) y 2) MHP (GMHP). Una hora después de la instalación del bloqueo espinal, fue realizada MHP en el GMHP aplicando una presión positiva en las vías aéreas en los niveles (BIPAP) con una presión espiratoria de 20 cmH2O y una presión inspiratoria de 20 cmH2O durante 1 a 2 minutos. FNTα, IL-1, IL-6, IL-8, IL-10 y IL-12 se midieron en la sangre a través de la técnica de citometría de flujo en los momentos basal, 90, 180 y 780 minutos. Los volúmenes y el peso pulmonares fueron computados a partir de tomografías computadorizadas obtenidas inmediatamente después de la operación. RESULTADOS: La aplicación de MHP resultó en una reducción de la fracción del parénquima pulmonar no aerado (7,5 ± 4,3 por ciento en el Grupo Control vs 4 ± 2,1 por ciento en el Grupo MHP, p = 0,02), sin alteraciones en los volúmenes pulmonares. Se observó una elevación progresiva en los valores plasmáticos de las interleucinas IL-1, IL-6, IL-8 y IL-10, similar en los dos grupos. Los niveles plasmáticos de FNT< y IL-12 no se detectaron durante el estudio. CONCLUSIONES: La aplicación de MHP única redujo la fracción de atelectasias, sin embargo, no amplificó la respuesta inflamatoria observada en pacientes con pulmones normales sometidos a cirugías de pequeño y mediano porte bajo anestesia subaracnoidea.


Subject(s)
Humans , Anesthesia, Conduction , Pulmonary Atelectasis/complications , Insufflation/methods , Positive-Pressure Respiration , Respiration, Artificial , Systemic Inflammatory Response Syndrome/complications
10.
Rev. chil. obstet. ginecol ; 75(3): 172-178, 2010. ilus, tab
Article in Spanish | LILACS | ID: lil-577410

ABSTRACT

Antecedentes: El síndrome de respuesta inflamatoria fetal (SRIF) es una entidad relacionada con la presencia de inflamación intrauterina y suele asociarse a infección intraamniótica. Su consecuencia más grave es la lesión cerebral y posterior desarrollo de parálisis cerebral. Objetivo: Evaluar la relación entre el síndrome de respuesta inflamatoria fetal y el desarrollo de complicaciones neonatales. Método: Estudio descriptivo y retrospectivo, realizado en el Hospital Universitario La Paz de Madrid, buscando una aproximación al SRIF desde la corioamnionitis histológica/funiculitis. El grupo de estudio constituido por 35 gestaciones simples pretérmino recogidas durante el primer semestre de 2008 y en las que la anatomía patológica de la placenta y anexos ovulares demostró la presencia de una corioamnionitis histológica y/o funiculitis. Resultados: Siete casos (20 por ciento) presentaban clínica sospechosa de infección intraamniótica, si bien en 28 gestantes (80 por ciento) existían factores de riesgo asociados al síndrome de respuesta inflamatoria fetal. Mortalidad perinatal en el grupo estudiado fue de 11,4 por ciento (4 casos). Sólo en 2 pacientes (5,7 por ciento) se pudo relacionar la muerte con el SRIF. En 28 recién nacidos (80 por ciento) se encontró algún tipo de patología, siendo la misma inherente a dicho síndrome en 17 casos (48,6 por ciento), destacando sepsis neonatal (40 por ciento), leucomalacia periventricular (14,3 por ciento) y displasia broncopulmonar (5,7 por ciento). Conclusión: Se comprueba el alto riesgo neonatal del SRIF. El conocimiento de esta condición, abre una serie de controversias diagnósticas y terapéuticas que obliga a una reevaluación de los protocolos actuales de manejo de la amenaza de parto pretérmino y la rotura prematura de membranas de pretérmino.


Background: The fetal inflammatory response syndrome (FIRS) is an entity related to intrauterine inflammation which is commonly associated with intraamniotic infection. The most serious consequence is the neurologic damage and the subsequent development of cerebral palsy. Aims: To evaluate the relationship between the fetal inflammatory response syndrome and the development of neonatal complications. Method: Descriptive and retrospective study realized in "La Paz" University Hospital of Madrid, looking for an approximation to the FIRS from histologic chorioamnionitis/funisitis. Group of study constituted by 35 single preterm gestations collected during the first semester of 2008 and in which the pathologic anatomy study of the placenta and annexes showed the presence of histological corioamnionitis and / or funisitis. Results: Suspicious clinic was found in 7 cases (20 percent) but in 28 cases (80 percent) risk factors associated to FIRS were present. Perinatal mortality found was 11.4 percent (4 cases). Only in 2 cases (5.7 percent) the cause was relationated with FIRS. Pathology associated was found in 28 newborn (80 percent), being 17 cases (48.6 percent) pathology associated with the fetal inflammatory response syndrome, enhancing neonatal sepsis (40 percent), periventricular leukomalacia (14.3 percent), and bronchopulmonar dysplasia (5.7 percent). Conclusion: It is verified that FIRS enteals a high neonatal risk. The knowledge of this entity opens some diagnostic and therapeutic controversies. Current management protocols of preterm labor and preterm premature rupture of membranes should be revised.


Subject(s)
Humans , Male , Female , Pregnancy , Infant, Newborn , Chorioamnionitis/pathology , Cerebral Palsy/etiology , Systemic Inflammatory Response Syndrome/complications , Chorioamnionitis/epidemiology , Infant Mortality , Leukomalacia, Periventricular/epidemiology , Leukomalacia, Periventricular/etiology , Morbidity , Pregnancy Complications, Infectious , Premature Birth , Cerebral Palsy/epidemiology , Risk Factors , Spain , Systemic Inflammatory Response Syndrome/epidemiology
12.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 19(2): 237-242, abr.-jun. 2009. ilus
Article in Portuguese | LILACS | ID: lil-525968

ABSTRACT

O choque cardiogênico é caracterizado como um estado de hipoperfusão sistêmica secundária a disfunção cardíaca grave. Clinicamente é definido como pressão sistólica abaixo de 90mmHg ou queda da pressão arterial média de 30 mmHg em relação ao basal. Em termos hemodinâmicos, é definido como índice cardíaco menor que 1,8 1/min/m2 sem suporte ou entre 2,0 1/min/m2 e 2,2 1/min/m2 com suporte, além de pressão capilar pulmonar elevada em, pelo menos, 15 mmHg. Sua principal etiologia é o infarto agudo do miocárdio com supradesnivelamento de ST. Estudos recentes tem demonstrado que cerca de 20 por cento dos pacientes com choque cardiogênico evoluem com características clínicas e hemodinâmicas de resposta inflamatória sistêmica caracterizada por febre, leucocitose e diminuição da resistência vascular sistêmica. Neste artigo discutiremos esses aspectos e as implicações dessa apresentação.


Subject(s)
Humans , Shock, Cardiogenic/complications , Shock, Cardiogenic/diagnosis , Sepsis/complications , Systemic Inflammatory Response Syndrome/complications , Systemic Inflammatory Response Syndrome/diagnosis
13.
Article in English | IMSEAR | ID: sea-46360

ABSTRACT

BACKGROUND: Various scoring systems have been developed to prioritize patient admission and management in ICU. The objective of this prospective, observational cohort study was to evaluate application of one such system, the Sequential Organ Failure Assessment (SOFA) Score in predicting outcome in ICU patients with SIRS. PATIENTS AND METHODS: Fifty patients admitted to a six bed multidisciplinary ICU with SIRS were consecutively enrolled in the study and SOFA scores were calculated at zero hour, after 48 hrs, and after 96 hrs and patients followed till discharge from hospital. RESULTS: When compared to outcome, the non survivors had high initial, mean and highest SOFA scores as compared to survivors. (p value = 0.002, <0.001, <0.001 respectively). Delta SOFA was not significantly associated with outcome. (p value= 0.117). The initial SOFA score > 11 predicted a mortality of 90%. (OR 23.72, 95%CI2.68-209.78, p=0.004). Similarly, mean SOFA score of > 7 predicted a mortality of 73.9% (OR 22.7, 95%CI 5.0 - 103.5, p<0.001) and high SOFA score > 11 predicted a mortality of 87.5% (OR 32.66, 95%CI 5.82-183.179, p< 0.001). Area under receiver operating characteristic (ROC) curve for mean SOFA was 0.825, for high SOFA was 0.817 and for initial SOFA was 0.708. Thus mean, high and initial SOFA scores were helpful in predicting between the survivors and the non survivors. CONCLUSION: The SOFA scoring system is useful in predicting outcomes in ICU and thus help in proper utilization of ICU resources.


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Intensive Care Units , Male , Middle Aged , Multiple Organ Failure/mortality , Nepal/epidemiology , Predictive Value of Tests , Prognosis , Prospective Studies , ROC Curve , Severity of Illness Index , Survival Analysis , Systemic Inflammatory Response Syndrome/complications
14.
Rev. cuba. med ; 43(5/6)sep.-dic. 2004.
Article in Spanish | LILACS | ID: lil-412066

ABSTRACT

Se hizo una revisión sobre la encefalopatía, un deterioro del estado mental o el nivel de conciencia iniciado por procesos extracerebrales. Por su parte, la sepsis desde hace algún tiempo, se está definiendo como la evidencia de infección más la presencia de una respuesta inflamatoria sistémica. Se ha observado que la encefalopatía séptica, descrita por primera vez en 1827, recientemente se ha convertido en un tema de interés neurológico global. Se ha reportado en hasta el 70 por ciento de los pacientes sépticos. La fisiopatología de esta entidad es sin duda muy compleja y oscura lo que nos motivó a realizar este trabajo, por ser la forma más común de encefalopatía en las unidades de cuidados progresivos


Subject(s)
Humans , Encephalitis , Sepsis , Systemic Inflammatory Response Syndrome/complications
15.
Rev. Soc. Boliv. Pediatr ; 43(1): 18-20, 2004. ilus
Article in Spanish | LILACS | ID: lil-385101

ABSTRACT

El mona es una infección gangrenosa aguda que afecta la cavidad oral y cara, dejando secuelas estéticas y funcionales profundas. El origen de la afección no se ha establecido plenamente, sin embargo destacan la desnutrición y otros padecimientos que alteran el sistema inmune como factores de riesgo importantes. El tratamiento se basa en la administración de antimicrobianos y reparación quirúrgica del defecto. Se describe el caso de un niño de dos años con una lesión profunda localizada en el surco nasogeniano derecho, asociada a desnutrición proteico-calórica, quien fue tratado con penicilina y clindamicina, y sometido a secuestrectomía y desfocalización con resultados favorables. En el texto se mencionan aspectos actualizados de la enfermedad


Subject(s)
Humans , Male , Child , Gangrene , Noma , Tissues , Systemic Inflammatory Response Syndrome/classification , Systemic Inflammatory Response Syndrome/complications , Systemic Inflammatory Response Syndrome/diagnosis
19.
Acta méd. colomb ; 26(4): 149-157, jul.-ago. 2001. tab, graf
Article in Spanish | LILACS | ID: lil-358373

ABSTRACT

Objetivo: desarrollar un índice de severidad para el síndrome de respuesta inflamatoria sistémica (SRIS) de etiología infecciosa comprobada o probable, que determine la probabilidad de muerte desde el momento de la admisión en urgencias. Diseño: estudio observacional analítico en una cohorte concurrente. Lugar de estudio: servicios de urgencias del Hospital Universitario San Vicente de Paúl y el Hospital General de Medellín Luz Castro de Gutiérrez. Pacientes: admitidos por urgencias con SRIS de etiología no traumática entre agosto de 1998 y marzo de 1999, de edad igual o superior a 14 años y con cambios en la temperatura o en el recuento de blancos como uno de los criterios necesarios para la definición del síndrome. Intervenciones: reclutamiento de la población de estudio y recolección de la información pertinente, de manera directa, en los servicios de urgencias de las dos instituciones. Mediciones: variables predictivas: edad, enfermedad sistémica inmunosupresora (ESI: cáncer, SIDA, uso de esferoides o quimioterapia), enfermedad sistémica general (ESG: insuficiencia cardíaca, insuficiencia renal, diabetes, enfermedad pulmonar obstructiva crónica o cirrosis), índice de choque, temperatura, frecuencia respiratoria, escala de Glasgow, recuento de leucocitos, recuento de plaquetas y valor de creatinina. Variable de desenlace: mortalidad intrahospitalaria dentro de los primeros 30 días de la admisión por urgencias. Análisis bivariado exploratorio y análisis de regresión logística paso a paso, asignación de puntaje de acuerdo con los coeficientes de regresión de las variables admitidas, evaluación de la capacidad discriminativa por medio del índice C y de la capacidad predictiva por medio del estadístico de Hosmer-Lemeshow. Resultados: fueron admitidos 533 pacientes, 45 por ciento mujeres, con un promedio de edad de 48 años y una estancia hospitalaria media de 11 días. El 14 por ciento requirió manejo en cuidado intensivo. Los principales diagnósticos de admisión fueron neumonía (36.3 por ciento), infección de piel y tejidos blandos (17 por ciento) y bacteremia o sepsis (13 por ciento...


Subject(s)
Prognosis , Systemic Inflammatory Response Syndrome/complications , Systemic Inflammatory Response Syndrome/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL